BioWorld MedTech

March 7, 2019

View Archived Issues

Patients tell their stories as Congress continues to shine light on pricing

Read More

Next G20 meeting to focus on funding mechanisms for global health care R&D

Read More

A Bug's Life 2: Seventure closing in on second microbiome fund

Read More

Beetles sing money tune as Verrica result punches cantharidin ticket to ride

Read More

Appointments and advancements

Read More

Financings

Read More

Daily M&A

Read More

Regulatory front

Read More

Product briefs

Read More

Other news to note

Read More

BioWorld MedTech's Orthopedics Extra

Read More

Neuronetics shines in fourth quarter, with Neurostar seeing a revenue bump

Neuronetics Inc. reported solid results for its fourth quarter, seeing revenue for its Neurostar Advanced Therapy come in at $4.8 million. That represented an increase of 37 percent vs. the prior year's figure of $3.5 million. Read More

Panel gives Optune positive scores for Medicare outcomes

Read More